İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2022 · article

The predictors of long–COVID in the cohort of Turkish Thoracic Society– TURCOVID multicenter registry: One year follow–up results

YÖKSİS OpenAlex Açık erişim · diamond
Yıl2022
Atıf13OpenAlex
Yüzdelik%84,4
FWCI1,531,00 = dünya ortalaması
Scopus (SJR)Q3
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıAsian Pacific Journal of Tropical Medicine
  • Katalog eşleşmesi (ISSN)Asian Pacific Journal of Tropical Medicine
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

Abstract Objective: To evaluate long-term effects of COVID-19, and to determine the risk factors in long-COVID in a cohort of the Turkish Thoracic Society (TTS)-TURCOVID multicenter registry. Methods: Thirteen centers participated with 831 patients; 504 patients were enrolled after exclusions. The study was designed in three-steps: (1) Phone questionnaire; (2) retrospective evaluation of the medical records; (3) face-to-face visit. Results: In the first step, 93.5% of the patients were hospitalized; 61.7% had a history of pneumonia at the time of diagnosis. A total of 27.1% reported clinical symptoms at the end of the first year. Dyspnea (17.00%), fatigue (6.30%), and weakness (5.00%) were the most prevalent long-term symptoms. The incidence of long-term symptoms was increased by 2.91 fold (95% CI 1.04-8.13, P =0.041) in the presence of chronic obstructive pulmonary disease and by 1.84 fold (95% CI 1.10-3.10, P =0.021) in the presence of pneumonia at initial diagnosis, 3.92 fold (95% Cl 2.29-6.72, P =0.001) of dyspnea and 1.69 fold (95% Cl 1.02-2.80, P =0.040) fatigue persists in the early-post-treatment period and 2.88 fold (95% Cl 1.52- 5.46, P =0.001) in the presence of emergency service admission in the post COVID period. In step 2, retrospective analysis of 231 patients revealed that 1.4% of the chest X-rays had not significantly improved at the end of the first year, while computed tomography (CT) scan detected fibrosis in 3.4%. In step 3, 138 (27.4%) patients admitted to face-to-face visit at the end of first year; at least one symptom persisted in 49.27% patients. The most common symptoms were dyspnea (27.60%), psychiatric symptoms (18.10%), and fatigue (17.40%). Thorax CT revealed fibrosis in 2.4% patients. Conclusions: COVID-19 symptoms can last for extended lengths of time, and severity of the disease as well as the presence of comorbidities might contribute to increased risk. Long-term clinical issues should be regularly evaluated after COVID-19.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

13atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yerel katalogda bu makaleye atıf yapan 38 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

  1. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  2. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  3. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  4. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  5. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  6. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  7. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  8. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  9. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex
  10. 2024 Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-UpAtıf 5 · OpenAlex

Yazarlar

37
  1. SERAP ARGUN BARIŞ 1
  2. OYA BAYDAR TOPRAK 2
  3. PELİN DURU ÇETİNKAYA 3
  4. FÜSUN FAKILI 4
  5. NURDAN KÖKTÜRK 5
  6. SEVAL KUL HALTER 6
  7. ÖZGECAN KAYALAR 7
  8. YILDIZ TÜTÜNCÜ İNÖNÜ ÜNİVERSİTESİ 8
  9. EMEL AZAK KARALİ 9
  10. MUTLU KULUÖZTÜRK 10
  11. PINAR AYSERT YILDIZ 11
  12. PELİN PINAR DENİZ 12
  13. OĞUZ KILINÇ 13
  14. İLKNUR BAŞYİĞİT 14
  15. HAŞİM BOYACI 15
  16. İSMAİL HANTA 16
  17. NESLİHAN KÖSE 17
  18. GÜLSEREN SAĞCAN 18
  19. ÇAĞLAR ÇUHADAROĞLU 19
  20. HACER KUZU OKUR 20
  21. HASAN SELÇUK ÖZGER 21
  22. BEGÜM ERGAN 22
  23. MEHTAP HAFIZOĞLU 23
  24. ABDULLAH SAYINER İZMİR EKONOMİ ÜNİVERSİTESİ 24
  25. ESRA NURLU TEMEL 25
  26. ÖNDER ÖZTÜRK 26
  27. TANSU ULUKAVAK ÇİFTÇİ 27
  28. İPEK KIVILCIM OĞUZÜLGEN 28
  29. VİLDAN AVKAN OĞUZ 29
  30. FIRAT BAYRAKTAR 30
  31. ÖZLEM ATAOĞLU DÜZCE ÜNİVERSİTESİ 31
  32. MERVE ERÇELİK KONCAK 32
  33. PINAR YILDIZ 33
  34. AYŞEGÜL TOMRUK ERDEM 34
  35. MÜGE MELTEM TOR 35
  36. BAHRİYE OYA İTİL 36
  37. HASAN BAYRAM 37